Navigation Links
New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
Date:11/27/2007

Dr. Jim Kim joins teleconference to release report with ITPC. Kim says foundations laid by AIDS response are "the best chance we've ever had to build comprehensive health systems in the poorest settings."

NEW YORK AND CAPE TOWN, South Africa, Nov.27 /PRNewswire-USNewswire/ -- The International Treatment Preparedness Coalition (ITPC), a group of 1,000 treatment activists from more than 125 countries, today issued its fifth report on scale up of AIDS services: Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. The report is available at http://www.aidstreatmentaccess.org.

The comprehensive report investigates AIDS drug access in 14 countries and finds that scale up is working but high prices, patent and registration barriers, and ongoing stock-outs are core issues impeding better and faster AIDS drug delivery.

"The foundations to make the 2010 target are in place in many countries. If governments, global agencies, and drug companies focus on tactically improving AIDS drug access by continually lowering costs, ending patent and regulatory problems, and fixing drug availability logistics, while simultaneously strengthening health systems, there is real possibility for making the 'near universal access' target by 2010," said Gregg Gonsalves, a coordinator of the project.

Missing the Target teams in nine countries -- Cambodia, Cameroon, China, Dominican Republic, India, Kenya, Russia, Zambia, and Zimbabwe -- also looked at broader issues in AIDS service delivery in their countries. "AIDS treatment scale up cannot succeed without stronger health systems, adequate nutrition, and concerted action against stigma and marginalization," said Matilda Moyo of the Zimbabwe research team.

"Mobilization around AIDS has opened up fantastic new possibilities in health service delivery by infusing new resources, intensifying the engagement
'/>"/>

SOURCE International Treatment Preparedness Coalition
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...egadoBiosciences,aprivatelyheldcompanyleadingthede...agents,announcedthatDavidMazzo,PhD,CEOandPresident...CareConferenceattheNewYorkPalaceHotelinNewYorkCity...uesday,December1andwillincludeanoverviewoftheCompa...m,theanticoagulantsystem,REG1.Thehealthcareindustr...
(Date:11/25/2009)...SwissrayInternational,Inc.aleadingmanufacturerofdi...ythatitsoperationshavebeenacquiredbyaprivateSwissI...dicalimagingbrand.Theacquisitionincludedallassetsa...ry.After25yearsofsuccessandgrowthSwissrayisnowpois...ithstableandsteadygrowth. ,, "Swissrayhaslongbe...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...SMarketTrends&Analysis http://www.reportlinke...t-Trends--Analysis.html ,, TheUSintranasaldrug...applicationsfromthedeliveryofconventionallocalther...s.Thefutureofthetechnologyhingesontotheeffectiveex...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 1Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 2Hard to Treat Diseases Inc 28HTDS 29 Targets an EU Based Stem Cell Research Company for a Merger 60321 3OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 1OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 2OxySure 28R 29 Aids Student in School Respiratory Arrest 3A WFAA Channel 8 News 5835 3Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 1Burton Medicals New Diagnostic Examination Light the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life 5833 2
...uropean Participants in Phase 3 AGENDA Tri...EY HEIGHTS, N.J., Sept. 5 /PRNewswire-FirstCall/ -...t data from the Company,s Phase 3,trial of Genasen...be,presented at the opening session of the first W...European Association of Dermato-Oncology (EADO).,G...
...resentation at 47th ICAAC on .... 4 Ardea Biosciences,Inc. (Pink Sheets: ARDC) an...hase 1 single-ascending-dose, multiple-ascending-d...RDEA806, a novel HIV non-nucleoside reverse,transc... The data from these Phase 1 clinical trials, toge...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
(Date:11/25/2009)...ous behavior problems that can occur in children w...ith a treatment plan that includes medication comb...s, according to Yale University researchers and th...9 issue of the Journal of the American Academy of...onducted by the National Institute of Mental Healt...
(Date:11/25/2009)... Nationwide Imaging Services, known...ions for diagnostic imaging equipment, now offerin...ding financing options, service and installation w... Medical Technologies of California) , ...-- Nationwide Imaging Services is proud to announc...
(Date:11/25/2009)...SHINGTON,Nov.25/PRNewswire-FirstCall/--TheAdvisory...lparticipateinthe21stAnnualPiperJaffrayHealthCareC...ecember2,2009at3:00PM(EST),willbetheCompany,sChief...,sChiefFinancialOfficer,MichaelT.Kirshbaum.Thepres...ite,foundat http://www.advisoryboardcompany.com ,t...
(Date:11/25/2009)...LTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,llc www...ptimalhealthscience.com havefileda67-pagefederalla....com,Inc.,JesseWillms,FarendServicesLimited,andAtL...itedStatesDistrictCourtfortheDistrictofUtah,allege...lesmile(TM)brandedteethwhiteningproducts,violation...
(Date:11/25/2009)...CaliforniaMakesLittleProgresstoImproveOverallOutco...ire-USNewswire/-- Today,LungCancerAlliance-Califo...cer .The2009ReportCardisanassessmentofprogressbein...a.LCA-CAisachapterofLungCancerAlliance(LCA),theonl...supportandadvocacyforpeoplelivingwithoratriskforlu...
Breaking Medicine News(10 mins):Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2
...overweight or obese have increased blood pressure ...e increased long-term risk of kidney damage previo...paper being presented at the American Society of N... in overweight donors after donation," comments Dr...
...astric bypass surgery for morbid obesity have incr...nes, //according to a paper being presented at the...ing and Scientific Exposition in San Diego. '...Rajiv Kumar of Mayo Clinic College of Medicine in ...
...p-with 1,000 pyres began Friday here to ward off d...hanting of Vedic hymns by Hindu priests from acros...ir heads, the ritual was performed with the lighti...was to ward off dengue, malaria and other diseases...
... here was virtually crippled Saturday as over 300 ...owing the attack on one of them //by relatives of ... The resident doctors-the mainstay in any medica...patient stormed the emergency ward and thrashed th...
... repeated panic attacks are less likely to have pr...health complications //and poorer quality of life,...n, Ph.D., a researcher with Group Health Cooperati...unctioning. 'But because panic and depression so o...
...in Scotland for the treatment of breast cancers in...o be beneficial // specifically in treating breast...idex is an aromatase inhibitor that works by inhib...and Wales also intend to introduce this drug into ...
Other Medicine News:Health News:Kidney Blood Flow May Explain Increased Long-Term Risks for Obese Kidney Donors 2Health News:Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk 2Health News:Panic Attacks Can Increase Complications in Diabetes Patients 2
...sign with 10mm diameter contact surface is ideal f...aturety (ROP) and other infant conditions. It has ...nosis and treatment of the pediatric patient as we...ures. Developed with Hideyuki Hayashi, MD. Comes w...
...s been specifically designed for small pupil exami...act slit lamp lenses do not provide adequate views...; dynamic field of view and can be used with pupil... Comes Standard with Volk's exclusive ANF+ (Advanc...
...ultra wide-field viewing and outstanding small pup...s at the slit lamp. It has been specifically desig...pupils without the hassle and steep learning curve...edible 124° dynamic field of view with ample ....
30D
Medicine Products: